Osimertinib improves progression-free survival in NSCLC
- PMID: 28284589
- DOI: 10.1016/S2213-2600(17)30085-1
Osimertinib improves progression-free survival in NSCLC
Comment on
-
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.N Engl J Med. 2017 Feb 16;376(7):629-640. doi: 10.1056/NEJMoa1612674. Epub 2016 Dec 6. N Engl J Med. 2017. PMID: 27959700 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
